Institutions Own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Shares but Private Equity Firms Control 44% of the Company
Yahoo FinanceApr 14 09:50 ET
Tenaya Therapeutics' Strategic Advantages in Cardiovascular Genetic Medicine Garner Buy Rating
TipRanksApr 5 06:56 ET
Optimistic Buy Rating for Tenaya Therapeutics Based on Promising Gene Therapy Pipeline and Upcoming Clinical Milestones
TipRanksMar 28 07:05 ET
20 Countries With the Highest Heart Disease Deaths Per Capita
Yahoo FinanceMar 26 07:19 ET
Express News | Chardan Capital Reiterates Buy on Tenaya Therapeutics, Maintains $20 Price Target
Moomoo 24/7Mar 21 12:52 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vera Therapeutics (VERA), Tyra Bioscience (TYRA) and Tenaya Therapeutics (TNYA)
TipRanksMar 21 08:50 ET
Buy Rating Affirmed for Tenaya Therapeutics: A Combination of Solid Financials and Promising Clinical Pipeline
TipRanksMar 21 02:17 ET
Analysts Are Bullish on Top Healthcare Stocks: Tenaya Therapeutics (TNYA), Sera Prognostics (SERA)
TipRanksMar 20 22:30 ET
Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity
Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity
Dow JonesMar 20 07:54 ET
Express News | Canaccord Genuity Maintains Buy on Tenaya Therapeutics, Lowers Price Target to $18
Moomoo 24/7Mar 20 07:44 ET
Tenaya Therapeutics Inc Reports Full Year and Q4 2023 Financial Results
Yahoo FinanceMar 20 05:32 ET
Express News | HC Wainwright & Co. Reiterates Buy on Tenaya Therapeutics, Maintains $18 Price Target
Moomoo 24/7Mar 19 07:09 ET
Tenaya Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/19/2024 273.44% HC Wainwright & Co. → $18 Reiterates Buy → Buy 11/30/2023 45.23% Leerink Partners → $7
BenzingaMar 19 07:08 ET
Analysts' Top Healthcare Picks: Inventiva (IVA), Tenaya Therapeutics (TNYA)
TipRanksMar 19 06:40 ET
Buy Rating Justified by Tenaya Therapeutics' Strong Financials and Promising Cardiovascular Pipeline Progress
TipRanksMar 19 06:25 ET
TD Cowen Keeps Their Buy Rating on Tenaya Therapeutics (TNYA)
TipRanksMar 18 23:55 ET
Express News | Tenaya Therapeutics Q4 EPS $(0.40) Beats $(0.44) Estimate
Moomoo 24/7Mar 18 16:09 ET
Press Release: Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Initial Data from Ongoing MyPeak(TM)-1 Phase 1b of TN-201 for MYBPC3-associated HCM Expect
Dow JonesMar 18 16:05 ET
Tenaya Therapeutics 4Q Loss/Shr 40c >TNYA
Tenaya Therapeutics 4Q Loss/Shr 40c >TNYA
Dow JonesMar 18 16:05 ET
Express News | Tenaya Therapeutics Publishes TN-401 Gene Therapy Preclinical Data In Nature Communications Medicine
Moomoo 24/7Mar 18 08:34 ET
No Data
No Data